Commentary: The schizophrenia prodrome: a high-risk concept.
Identifieur interne : 004474 ( Main/Exploration ); précédent : 004473; suivant : 004475Commentary: The schizophrenia prodrome: a high-risk concept.
Auteurs : Alison R. Yung [Australie]Source :
- Schizophrenia bulletin [ 0586-7614 ] ; 2003.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Enfant (MeSH), Essais cliniques comme sujet (MeSH), Humains (MeSH), Neuroleptiques (administration et posologie), Psychologie des schizophrènes (MeSH), Recherche (MeSH), Risque (MeSH), Schizophrénie (diagnostic), Schizophrénie (prévention et contrôle), Schizophrénie (épidémiologie), Surveillance de la population (MeSH), Terminologie comme sujet (MeSH), Trouble de la personnalité schizotypique (diagnostic), Trouble de la personnalité schizotypique (prévention et contrôle), Trouble de la personnalité schizotypique (psychologie), Trouble de la personnalité schizotypique (épidémiologie), Victoria (MeSH), Échelles d'évaluation en psychiatrie (MeSH), Études transversales (MeSH), Évolution de la maladie (MeSH).
- MESH :
- administration et posologie : Neuroleptiques.
- diagnostic : Schizophrénie, Trouble de la personnalité schizotypique.
- prévention et contrôle : Schizophrénie, Trouble de la personnalité schizotypique.
- psychologie : Trouble de la personnalité schizotypique.
- épidémiologie : Schizophrénie, Trouble de la personnalité schizotypique.
- Adolescent, Adulte, Enfant, Essais cliniques comme sujet, Humains, Psychologie des schizophrènes, Recherche, Risque, Surveillance de la population, Terminologie comme sujet, Victoria, Échelles d'évaluation en psychiatrie, Études transversales, Évolution de la maladie.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Antipsychotic Agents (administration & dosage), Child (MeSH), Clinical Trials as Topic (MeSH), Cross-Sectional Studies (MeSH), Disease Progression (MeSH), Humans (MeSH), Population Surveillance (MeSH), Psychiatric Status Rating Scales (MeSH), Research (MeSH), Risk (MeSH), Schizophrenia (diagnosis), Schizophrenia (epidemiology), Schizophrenia (prevention & control), Schizophrenic Psychology (MeSH), Schizotypal Personality Disorder (diagnosis), Schizotypal Personality Disorder (epidemiology), Schizotypal Personality Disorder (prevention & control), Schizotypal Personality Disorder (psychology), Terminology as Topic (MeSH), Victoria (MeSH).
- MESH :
- chemical , administration & dosage : Antipsychotic Agents.
- geographic : Victoria.
- diagnosis : Schizophrenia, Schizotypal Personality Disorder.
- epidemiology : Schizophrenia, Schizotypal Personality Disorder.
- prevention & control : Schizophrenia, Schizotypal Personality Disorder.
- psychology : Schizotypal Personality Disorder.
- Adolescent, Adult, Child, Clinical Trials as Topic, Cross-Sectional Studies, Disease Progression, Humans, Population Surveillance, Psychiatric Status Rating Scales, Research, Risk, Schizophrenic Psychology, Terminology as Topic.
DOI: 10.1093/oxfordjournals.schbul.a007052
PubMed: 14989420
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Commentary: The schizophrenia prodrome: a high-risk concept.</title><author><name sortKey="Yung, Alison R" sort="Yung, Alison R" uniqKey="Yung A" first="Alison R" last="Yung">Alison R. Yung</name><affiliation wicri:level="4"><nlm:affiliation>University of Melbourne, Department of Psychiatry and ORYGEN Youth Health (incorporating PACE and EPPIC), 35 Poplar Road, Parkville, 3052, Victoria, Australia. aryung@unimelb.edu.au</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>University of Melbourne, Department of Psychiatry and ORYGEN Youth Health (incorporating PACE and EPPIC), 35 Poplar Road, Parkville, 3052, Victoria</wicri:regionArea><orgName type="university">Université de Melbourne</orgName><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2003">2003</date><idno type="RBID">pubmed:14989420</idno><idno type="pmid">14989420</idno><idno type="doi">10.1093/oxfordjournals.schbul.a007052</idno><idno type="wicri:Area/Main/Corpus">004329</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">004329</idno><idno type="wicri:Area/Main/Curation">004329</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">004329</idno><idno type="wicri:Area/Main/Exploration">004329</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Commentary: The schizophrenia prodrome: a high-risk concept.</title><author><name sortKey="Yung, Alison R" sort="Yung, Alison R" uniqKey="Yung A" first="Alison R" last="Yung">Alison R. Yung</name><affiliation wicri:level="4"><nlm:affiliation>University of Melbourne, Department of Psychiatry and ORYGEN Youth Health (incorporating PACE and EPPIC), 35 Poplar Road, Parkville, 3052, Victoria, Australia. aryung@unimelb.edu.au</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>University of Melbourne, Department of Psychiatry and ORYGEN Youth Health (incorporating PACE and EPPIC), 35 Poplar Road, Parkville, 3052, Victoria</wicri:regionArea><orgName type="university">Université de Melbourne</orgName><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author></analytic><series><title level="j">Schizophrenia bulletin</title><idno type="ISSN">0586-7614</idno><imprint><date when="2003" type="published">2003</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Antipsychotic Agents (administration & dosage)</term><term>Child (MeSH)</term><term>Clinical Trials as Topic (MeSH)</term><term>Cross-Sectional Studies (MeSH)</term><term>Disease Progression (MeSH)</term><term>Humans (MeSH)</term><term>Population Surveillance (MeSH)</term><term>Psychiatric Status Rating Scales (MeSH)</term><term>Research (MeSH)</term><term>Risk (MeSH)</term><term>Schizophrenia (diagnosis)</term><term>Schizophrenia (epidemiology)</term><term>Schizophrenia (prevention & control)</term><term>Schizophrenic Psychology (MeSH)</term><term>Schizotypal Personality Disorder (diagnosis)</term><term>Schizotypal Personality Disorder (epidemiology)</term><term>Schizotypal Personality Disorder (prevention & control)</term><term>Schizotypal Personality Disorder (psychology)</term><term>Terminology as Topic (MeSH)</term><term>Victoria (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Enfant (MeSH)</term><term>Essais cliniques comme sujet (MeSH)</term><term>Humains (MeSH)</term><term>Neuroleptiques (administration et posologie)</term><term>Psychologie des schizophrènes (MeSH)</term><term>Recherche (MeSH)</term><term>Risque (MeSH)</term><term>Schizophrénie (diagnostic)</term><term>Schizophrénie (prévention et contrôle)</term><term>Schizophrénie (épidémiologie)</term><term>Surveillance de la population (MeSH)</term><term>Terminologie comme sujet (MeSH)</term><term>Trouble de la personnalité schizotypique (diagnostic)</term><term>Trouble de la personnalité schizotypique (prévention et contrôle)</term><term>Trouble de la personnalité schizotypique (psychologie)</term><term>Trouble de la personnalité schizotypique (épidémiologie)</term><term>Victoria (MeSH)</term><term>Échelles d'évaluation en psychiatrie (MeSH)</term><term>Études transversales (MeSH)</term><term>Évolution de la maladie (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antipsychotic Agents</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Victoria</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Neuroleptiques</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Schizophrenia</term><term>Schizotypal Personality Disorder</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Schizophrénie</term><term>Trouble de la personnalité schizotypique</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Schizophrenia</term><term>Schizotypal Personality Disorder</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Schizophrenia</term><term>Schizotypal Personality Disorder</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Schizophrénie</term><term>Trouble de la personnalité schizotypique</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Trouble de la personnalité schizotypique</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Schizotypal Personality Disorder</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Schizophrénie</term><term>Trouble de la personnalité schizotypique</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Child</term><term>Clinical Trials as Topic</term><term>Cross-Sectional Studies</term><term>Disease Progression</term><term>Humans</term><term>Population Surveillance</term><term>Psychiatric Status Rating Scales</term><term>Research</term><term>Risk</term><term>Schizophrenic Psychology</term><term>Terminology as Topic</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Enfant</term><term>Essais cliniques comme sujet</term><term>Humains</term><term>Psychologie des schizophrènes</term><term>Recherche</term><term>Risque</term><term>Surveillance de la population</term><term>Terminologie comme sujet</term><term>Victoria</term><term>Échelles d'évaluation en psychiatrie</term><term>Études transversales</term><term>Évolution de la maladie</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">14989420</PMID><DateCompleted><Year>2004</Year><Month>08</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0586-7614</ISSN><JournalIssue CitedMedium="Print"><Volume>29</Volume><Issue>4</Issue><PubDate><Year>2003</Year></PubDate></JournalIssue><Title>Schizophrenia bulletin</Title><ISOAbbreviation>Schizophr Bull</ISOAbbreviation></Journal><ArticleTitle>Commentary: The schizophrenia prodrome: a high-risk concept.</ArticleTitle><Pagination><MedlinePgn>859-65</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yung</LastName><ForeName>Alison R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>University of Melbourne, Department of Psychiatry and ORYGEN Youth Health (incorporating PACE and EPPIC), 35 Poplar Road, Parkville, 3052, Victoria, Australia. aryung@unimelb.edu.au</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016420">Comment</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Schizophr Bull</MedlineTA><NlmUniqueID>0236760</NlmUniqueID><ISSNLinking>0586-7614</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Schizophr Bull. 2003;29(4):653-69</RefSource><PMID Version="1">14989405</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>Schizophr Bull. 2003;29(4):671-92</RefSource><PMID Version="1">14989406</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>Schizophr Bull. 2003;29(4):693-701</RefSource><PMID Version="1">14989407</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>Schizophr Bull. 2003;29(4):703-15</RefSource><PMID Version="1">14989408</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>Schizophr Bull. 2003;29(4):717-28</RefSource><PMID Version="1">14989409</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>Schizophr Bull. 2003;29(4):737-45</RefSource><PMID Version="1">14989411</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>Schizophr Bull. 2003;29(4):747-56</RefSource><PMID Version="1">14989412</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>Schizophr Bull. 2003;29(4):757-69</RefSource><PMID Version="1">14989413</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>Schizophr Bull. 2003;29(4):771-90</RefSource><PMID Version="1">14989414</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>Schizophr Bull. 2003;29(4):791-801</RefSource><PMID Version="1">14989415</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>Schizophr Bull. 2003;29(4):803-30</RefSource><PMID Version="1">14989416</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>Schizophr Bull. 2003;29(4):831-43</RefSource><PMID Version="1">14989417</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012106" MajorTopicYN="N">Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012565" MajorTopicYN="Y">Schizophrenic Psychology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012569" MajorTopicYN="N">Schizotypal Personality Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009626" MajorTopicYN="N">Terminology as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014739" MajorTopicYN="N" Type="Geographic">Victoria</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>3</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>8</Month><Day>17</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>3</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14989420</ArticleId><ArticleId IdType="doi">10.1093/oxfordjournals.schbul.a007052</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Australie</li></country><region><li>Victoria (État)</li></region><settlement><li>Melbourne</li></settlement><orgName><li>Université de Melbourne</li></orgName></list><tree><country name="Australie"><region name="Victoria (État)"><name sortKey="Yung, Alison R" sort="Yung, Alison R" uniqKey="Yung A" first="Alison R" last="Yung">Alison R. Yung</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PoplarV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004474 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004474 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Bois
|area= PoplarV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:14989420
|texte= Commentary: The schizophrenia prodrome: a high-risk concept.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:14989420" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a PoplarV1
| This area was generated with Dilib version V0.6.37. |  |